We observed that genetic variation in the 3′UTR flanking region of the hormone regulation gene 3-beta-hydroxysteroid dehydrogenase type 2 (HSD3B2) was associated with nearly a two-fold increase in bladder cancer risk. This evidence concerns the gene HSD3B2 and urinary bladder carcinoma.